Procalcitonin (PCT) is a 116 amino acid residue protein with a molecular weight of approximately 13kDa. Procalcitonin is a peptide hormone mainly produced by the C cells of the thyroid and certain endocrine cells of the lung. Under normal expression conditions, procalcitonin is immediately cleaved into three specific fragments, an N terminal residue, calcitonin and katacalcin. It can be expressed in E. coli

Scope of the Report:
Sepsis is a life-threatening organ dysfunction caused by an excessive host immune response to a serious infection. According to the Centers for Disease Control and Prevention (CDC), 1.6 million Americans suffered from sepsis in 2011, of which about 260,000 did not survive. PCT can play a critical role in addressing this clinical challenge and has become a key component of successful sepsis protocols across the U.S. and Europe. PCT levels increase precipitously in patients with severe bacterial infection. PCT is therefore an extremely important biomarker enabling specific differentiation between a severe bacterial infection and other causes of inflammatory reactions.
Expressed in E.coli, PCT can be used as a reagent to prepare calibrators for procalcitonin or calcitonin immunoassays.

The global procalcitonin market had reached 126.4 g in 2016 and is expected to increase reach 212.6 g by 2023. In terms of revenue, the global procalcitonin chloride market was valued 61.85 Million USD in 2016, and is estimated to be worth 92.27 Million USD by 2023. Overall, the procalcitonin products performance is positive with the global economic recovery.

The manufacture region is concentrated in USA, Europe, China and Japan, of which Europe is the largest region with the share 36.92% in 2016. The production shares of Europe, China and Japan were 23.07%, 19.12% and 6.43%.

The consumption share of North America, Europe, Asia Pacific were 26.73%, 28.27%, 35.77% in 2016. Asia Pacific is the main export region.

There are companies adding new capacities and aims at the cost and quality leadership which shall improve profitability. As the same time, companies are focusing on technological innovation, equipment upgrades, and process improvements, to reduce costs and improve quality. The competition in Procalcitonin market will become more intense.

The worldwide market for Procalcitonin (CAS 56645-65-9) is expected to grow at a CAGR of roughly 6.4% over the next five years, will reach 90 million US$ in 2024, from 62 million US$ in 2019, according to a new GIR (Global Info Research) study.
This report focuses on the Procalcitonin (CAS 56645-65-9) in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.

Get Sample Copy : https://www.worldwidemarketreports.com/sample/254018

Market Segment by Manufacturers, this report covers :
Thermo Fisher
Roche Diagnostics
bioMerieux
HyTest
BBI Solutions
ProSpec
Wondfo
Ningbo Medicalsystem Biotechnology
Wuhan Easy Diagnosis Biomedicine
Snibe
Vazyme Biotech
Getein Biotech
Hotgen Biotech
Lumigenex
Nanjing Norman Biological Technology
Shanghai Medicine'nest Pharmaceutical
Kitgen
Beijing KeyGen
Beijing Apis

Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia etc.)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Market Segment by Type, covers
Procalcitonin Antigen
Procalcitonin Antibody

Market Segment by Applications, can be divided into
Medical Industry
Scientific Research

Get Discount : https://www.worldwidemarketreports.com/discount/254018

Table of Contents
1 Market Overview
2 Manufacturers Profiles
3 Global Procalcitonin (CAS 56645-65-9) Sales, Revenue, Market Share and Competition by Manufacturer (2017-2018)
4 Global Procalcitonin (CAS 56645-65-9) Market Analysis by Regions
5 North America Procalcitonin (CAS 56645-65-9) by Country
6 Europe Procalcitonin (CAS 56645-65-9) by Country
7 Asia-Pacific Procalcitonin (CAS 56645-65-9) by Country
8 South America Procalcitonin (CAS 56645-65-9) by Country
9 Middle East and Africa Procalcitonin (CAS 56645-65-9) by Countries
10 Global Procalcitonin (CAS 56645-65-9) Market Segment by Type
11 Global Procalcitonin (CAS 56645-65-9) Market Segment by Application
12 Procalcitonin (CAS 56645-65-9) Market Forecast (2019-2024)
13 Sales Channel, Distributors, Traders and Dealers
14 Research Findings and Conclusion
15 Appendix

Inquire Before Buying : https://www.worldwidemarketreports.com/quiry/254018

About WMR
Worldwide Market Reports is your one-stop repository of detailed and in-depth market research reports compiled by an extensive list of publishers from across the globe. We offer reports across virtually all domains and an exhaustive list of sub-domains under the sun. The in-depth market analysis by some of the most vastly experienced analysts provide our diverse range of clients from across all industries with vital decision making insights to plan and align their market strategies in line with current market trends. Worldwide Market Research’s well-researched inputs that encompass domains ranging from IT to healthcare enable our prized clients to capitalize upon key growth opportunities and shield against credible threats prevalent in the market in the current scenario and those expected in the near future.

Contact Us:
Mr. Shah
Worldwide Market Reports
Tel: +1 415 871 0703
Email: [email protected]
For more News Visit Website: www.coherentwire.com